-
EP2004167
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2004167
| EP2004167 - RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.07.2012 Database last updated on 31.08.2024 | Most recent event Tooltip | 20.07.2012 | Application deemed to be withdrawn | published on 22.08.2012 [2012/34] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | [N/P] |
| Former [2009/43] | For all designated states NOVARTIS AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | |||
| Former [2008/52] | For all designated states NOVARTIS AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Vienna / AT | Inventor(s) | 01 /
SATLIN, Andrew 350 Long Hill Drive Short Hills, New Jersey 07078 / US | [2008/52] | Representative(s) | Dietel-Manske, Anja Novartis International AG Corporate Intellectual Property Forum 1, Novartis Campus 4056 Basel / CH | [N/P] |
| Former [2008/52] | Dietel, Anja Novartis International AG Corporate Intellectual Property CH-4002 Basel / CH | Application number, filing date | 07759755.7 | 30.03.2007 | [2008/52] | WO2007US65564 | Priority number, date | US20060788842P | 03.04.2006 Original published format: US 788842 P | [2008/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007118023 | Date: | 18.10.2007 | Language: | EN | [2007/42] | Type: | A1 Application with search report | No.: | EP2004167 | Date: | 24.12.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.10.2007 takes the place of the publication of the European patent application. | [2008/52] | Search report(s) | International search report - published on: | EP | 18.10.2007 | Classification | IPC: | A61K31/165, A61P9/12 | [2008/52] | CPC: |
A61K31/165 (EP,US);
A61K31/175 (KR);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/12 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/52] | Extension states | HR | 03.11.2008 | Title | German: | RENIN-HEMMER ZUR BEHANDLUNG VON BLUTHOCHDRUCK | [2008/52] | English: | RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION | [2008/52] | French: | INHIBITEURS DE LA RÉNINE DESTINÉS AU TRAITEMENT DE L'HYPERTENSION | [2008/52] | Entry into regional phase | 03.11.2008 | National basic fee paid | 03.11.2008 | Designation fee(s) paid | 03.11.2008 | Examination fee paid | Examination procedure | 03.11.2008 | Examination requested [2008/52] | 24.02.2009 | Despatch of a communication from the examining division (Time limit: M06) | 20.08.2009 | Reply to a communication from the examining division | 09.09.2011 | Despatch of a communication from the examining division (Time limit: M06) | 20.03.2012 | Application deemed to be withdrawn, date of legal effect [2012/34] | 25.04.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/34] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.02.2009 | Fees paid | Renewal fee | 13.03.2009 | Renewal fee patent year 03 | 15.03.2010 | Renewal fee patent year 04 | 15.03.2011 | Renewal fee patent year 05 | 14.03.2012 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DX]EP0678503 (CIBA GEIGY AG [CH]) [DX] 1-40 * example 83 ** page 11, line 47 - line 52 *; | [X] - WOOD J M ET AL, "Structure-based design of aliskiren, a novel orally effective renin inhibitor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20030905), vol. 308, no. 4, ISSN 0006-291X, pages 698 - 705, XP004447169 [X] 1-40 * the whole document * * abstract * * page 703, paragraph 2 * * page 703, column R, paragraph L - page 704, column L, paragraph 2 * DOI: http://dx.doi.org/10.1016/S0006-291X(03)01451-7 | [X] - STANTON ALICE ET AL, "Blood pressure lowering in essential hypertension with an oral renin inhibitor, Aliskiren", HYPERTENSION, XX, XX, (200312), vol. 42, no. 6, ISSN 0194-911X, pages 1137 - 1143, XP002368887 [X] 1-40 * the whole document * * abstract * * page 1137, column L, paragraph 1 * * page 1141, column R, paragraph L * DOI: http://dx.doi.org/10.1161/01.HYP.0000101688.17370.87 | [X] - NUSSBERGER J ET AL, "ANGIOTENSIN II SUPPRESSION IN HUMANS BY THE ORALLY ACTIVE RENIN INHIBITOR ALISKIREN (SPP100): COMPARISON WITH ENALAPRIL", HYPERTENSION, XX, XX, (2002), vol. 39, ISSN 0194-911X, pages 1 - 8, XP008058561 [X] 1-40 * the whole document * * abstract * * page 3, column R, paragraph L - page 7, column L, paragraph L * DOI: http://dx.doi.org/10.1161/hy0102.102293 | [X] - MEALY N E ET AL, "ALISKIREN FUMARATE ANTIHYPERTENSIVE", DRUGS OF THE FUTURE, BARCELONA, ES, (2001), vol. 26, no. 12, ISSN 0377-8282, pages 1139 - 1148, XP009017211 [X] 1-40 * page 1146, column R, paragraph 2 - page 1147, column L, paragraph L * DOI: http://dx.doi.org/10.1358/dof.2001.026.12.648490 | [X] - WOOD JEANETTE M ET AL, "Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats", JOURNAL OF HYPERTENSION, CURRENT SCIENCE, PHILADELPHIA, PA, US, (200502), vol. 23, no. 2, ISSN 0263-6352, pages 417 - 426, XP009088709 [X] 1-40 * the whole document * * abstract * * page 424, column L, paragraph 5 * * page 424, column R, paragraph 2 * * page 425, column R, paragraph L * DOI: http://dx.doi.org/10.1097/00004872-200502000-00025 |